icer tirzepatide white paper affordable access to glp-1 obesity medications 2025 Payers Consider Policy Options for Access to GLP-1 Obesity Medications Newer Weight-Loss Drugs Not Cost-effective

Guidance From Your GP or Prescriber Before Starting Treatment A comprehensive medicines reconciliation review with your GP or specialist is essential before starting retatrutide, covering all current medicines, supplements, and relevant medical history

Understanding your genetic background in peptide pathways can support more granular conversations with your provider about expected mechanisms of action, personalized dosing strategies, or whether combination approaches might align better with your biology

J Am Soc Nephrol 2002;13:708-14

Hypoglycemia: While semaglutide does not usually cause low blood sugar (hypoglycemia) on its own, individuals taking it along with other medications like insulin may be at risk

Typical escalation DAY TO DAY Semaglutide for weight management is injected under the skin once a week, at any time of day, with or without food